Sankyo Articles

Chugai's Gen-Probe slips into the red

24 November 1999

Sankyo licenses Cholestagel in USA

16 November 1999

Sankyo turnover falls

15 November 1999

Stock Commentary Tokyo

11 November 1999

Japanese and WHO join in fight against malaria

8 November 1999

Sankyo Chinese JV to start selling in 2002

2 November 1999

Sankyo shifting R&D and marketing in USA

1 November 1999

"Rising tide" of pharma consolidation reviewed by banker

21 October 1999

Stock Commentary Tokyo

14 October 1999

Stock Commentary Tokyo

11 October 1999

Stock Commentary Tokyo

30 September 1999

Stock Commentary Tokyo

23 September 1999

Stock Commentary Tokyo

16 September 1999

Japan's drugmakers will have to "globalize"

10 September 1999

Stock Commentary Tokyo

9 September 1999

2000 set to be a dramatic year for Japan's drug industry says Lehman

2 September 1999

Stock Commentary Tokyo

2 September 1999

Stock Commentary Tokyo

19 August 1999

New drug discovery: is genomics delivering? asks Lehman Brothers

16 August 1999

Stock Commentary Tokyo

12 August 1999

Stock Commentary Tokyo

5 August 1999

Takeda and Yamanouchi are Japan's "most admired" pharmaceutical companies

2 August 1999

Stock Commentary Tokyo

29 July 1999

Stock Commentary Tokyo

22 July 1999

Pravastatin shown to be anti-inflammatory

20 July 1999

Pravastatin granted unstable angina license

14 July 1999

Sankyo and W-L in promotion campaign for Rezulin

6 July 1999

Sankyo set to sell stake in Organon

6 July 1999

Stock Commentary Tokyo

1 July 1999

Japanese pharmaceutical industry and firms reviewed by HSBC analysts

25 June 1999

Stock Commentary Tokyo

24 June 1999

Stock Commentary Tokyo

17 June 1999

Japanese drugmakers setting conservative targets for fiscal 2000

7 June 1999

Stock Commentary Tokyo

3 June 1999

Stock Commentary Tokyo

27 May 1999

Diabetes market to reach $20 billion a year by 2006, says Lehman Brothers

26 May 1999

Strong net profits growth for Sankyo

24 May 1999

NK-104 marketing deal in Japan

20 May 1999

Stock Commentary Tokyo

20 May 1999

Stock Commentary Tokyo

13 May 1999

Sankyo Pharma UK appointment

13 May 1999

New MD at Sankyo Pharma UK

6 May 1999

Stock Commentary Tokyo

29 April 1999

Analysts compare and contrast new glitazones from SB and Takeda

29 April 1999

Japanese pharmaceutical firms struggle to restructure - by P Reed Maurer

26 April 1999

SB boosted as Avandia is backed by FDA advisory panel; links with B-MS for

26 April 1999

SB boosted as Avandia is backed by FDA advisory panel

23 April 1999

Stock Commentary Tokyo

14 April 1999

Bayer sees Japan as growth area for future

8 April 1999

Stock Commentary Tokyo

31 March 1999

-Bayer to expand in Taiwan

31 March 1999

Troglitazone shows promise in cancer

30 March 1999

Stock Commentary Tokyo

29 March 1999

MCA rejects reintroduction of troglitazone in the UKMCA rejects

29 March 1999

Bayer buying out stake in Japanese JV

29 March 1999

MCA rejects reintroduction of troglitazone in the UK

23 March 1999

Survey of Japanese drugmakers shows mixed thoughts on results vs forecasts

15 March 1999

Stock Commentary Tokyo

11 March 1999

Sankyo Pharma Lipostat product manager appointed

11 March 1999

Sankyo Co subsidiaries to merge

11 March 1999

Stock Commentary Tokyo

4 March 1999

Stock Commentary Tokyo

25 February 1999

Lilly scraps Targretin development agreement with Ligand

24 February 1999

Troglitazone; great potential despite woes

18 February 1999

Takeda entering new phase of global expansion, says MSDW analyst

18 February 1999

Stock Commentary Tokyo

18 February 1999

Stock Commentary Tokyo

11 February 1999

Stock Commentary Tokyo

4 February 1999

Sankyo Pharma in UK promotes Nick Rhys-jones

4 February 1999

Stock Commentary Tokyo

28 January 1999

Stock Commentary Tokyo

20 January 1999

Rezulin up for FDA panel review on safety, plus new indications

19 January 1999

Stock Commentary Tokyo

14 January 1999

Sankyo Pharma UK appointment

14 January 1999

Stock Commentary Tokyo

7 January 1999

Kinetek starts Phase I with KP-102

22 December 1998

Stock Commentary Tokyo

17 December 1998

Sankyo Exports To Make Up 20% Of Sales

11 December 1998

Stock Commentary Tokyo

10 December 1998

Merger And Acquisition Prospects In Japan

7 December 1998

Stock Commentary Tokyo

3 December 1998

Graham Beer Promoted At Sankyo Pharma

3 December 1998

Stock Commentary Tokyo

26 November 1998

Pioglitazone; Competition For Rezulin/Avandia?

26 November 1998

Stock Commentary Tokyo

19 November 1998

B-MS To Take Up To $500M 4th-Qtr Charge

18 November 1998

Japanese Firms Report Disappointing Figures

18 November 1998

Stock Commentary Tokyo

5 November 1998

Stock Commentary Tokyo

29 October 1998

New Antibacterials Showcased At ICAAC

14 October 1998

SmithKline Beecham's Avandia Shines At Phase III

17 September 1998

Warner-Lambert's Lipitor And Rezulin Will Fuel Growth

9 September 1998

ALRT Buyback Affects Revenues At Ligand

24 August 1998

Stock Commentary Tokyo

6 August 1998

W-L's Lipitor "Will Be World Top-Seller In 2005"

3 August 1998

Rezulin Under Renewed Fire As Label Changes

29 July 1998

Sankyo Looking To Increase Exports

9 July 1998

Stock Commentary Tokyo

25 June 1998

Wyeth Withdraws Duract Due To Serious Liver Events

24 June 1998

Japan's Drugmakers Spending More On R&D

23 June 1998

Showing 601-700 of 998 articles

Go to beginning

Previous

1
2
3
4
5
6
7
8
9
10

Next

Go to end